An international research team has demonstrated that a new plant-derived drug can block the progression of multiple sclerosis (MS).
University of Queensland researcher Dr Christian Gruber said the breakthrough could be a step forward in preventing and treating MS and other autoimmune diseases.
“This is a really exciting discovery because it may offer a whole new quality of life for people with this debilitating disease,” he said.
The new drug is expected to be taken by mouth, in contrast to some current MS treatments where patients need to have frequent injections.
MS is a chronic incurable condition marked by attacks that bring gradual deterioration in the patient’s health. About 23,000 people are affected in Australia and 2.5 million worldwide.
Dr Gruber said the new drug – named T20K – was extracted from a traditional medicinal plant, the Oldenlandia affinis.
The drug treatment had been successful in an animal model, and patent applications filed in several countries.
“Phase one clinical trials could begin as early as 2018,” Dr Gruber said.
“Licences have been assigned to Cyxone, a company established last year to develop this new class of drugs for the treatment of autoimmune diseases.
“Cyxone’s immediate focus is on bringing T20K through the pre-clinical program required for delivering a safe, orally active drug.”
Dr Gruber said the new treatment arose from a synthesised plant peptide, a class of drugs known as cyclotides.
“Cyclotides are present in a range of common plants, and they show significant potential for the treatment of auto immune diseases,” he said.
“The T20K peptides exhibit extraordinary stability and chemical features that are ideally what you want in an oral drug candidate.”
The international research team demonstrated in an animal model that T20K stopped progression in the normal clinical symptoms of MS.
Learn more: Breakthrough may stop multiple sclerosis in its tracks
The Latest on: Multiple sclerosis
[google_news title=”” keyword=”multiple sclerosis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Multiple sclerosis
- Blood test might someday diagnose early MSon April 27, 2024 at 6:10 am
An early marker of multiple sclerosis could help doctors figure out who will eventually fall prey to the degenerative nerve disease, a new study says.
- PET brain scans could reveal hidden inflammation in patients with multiple sclerosison April 27, 2024 at 4:47 am
A Brigham and Women’s Hospital study of 30 people found that, in patients with MS, advanced brain imaging could identify hidden inflammation not picked up on traditional MRIs ...
- How Texas MS 150 brings in funds to fight the disease better than everon April 26, 2024 at 4:05 pm
Multiple sclerosis (MS) can be a devastating diagnosis that affects about a million people in the United States. The good news is there’s been more progress in MS than in any other neurological ...
- Texas MS 150 bike ride for multiple sclerosis fight to raise millionson April 26, 2024 at 2:55 pm
Texas MS150 is gearing up to celebrate its 40th anniversary as thousands of cyclists raise millions of dollars for the fight against Multiple Sclerosis.
- Multiple sclerosis: PET scans reveal 'hidden' inflammationon April 25, 2024 at 11:12 pm
A new study from Brigham and Women’s Hospital suggests positron emission tomography (PET) brain scans could reveal hidden inflammation in patients with multiple sclerosis (MS) who are being treated ...
- Great Falls woman continues advocacy for multiple sclerosis awarenesson April 25, 2024 at 4:00 pm
Tim McGonigal reported on Dawn Sexton of Great Falls, who works to raise awareness about multiple sclerosis. Now, Dawn is a featured guest on Tim's podcast.
- Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Receiving Intranasal Foralumabon April 25, 2024 at 9:00 am
*EA5 showed a worsening in their White Matter Z-Score at three months during a pseudo-exacerbation of the patient’s trigeminal neuralgia.
- Page settingson April 24, 2024 at 1:19 pm
Immigrants to Canada who have spent a greater proportion of their lives in Canada have a greater risk of developing multiple sclerosis (MS) than people who have spent a smaller proportion of their ...
- Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients in its Expanded Access Programon April 22, 2024 at 4:12 am
All Patients Have Either Stabilized or Improved on Nasal Foralumab Treatment and No Patients Declined in Key Clinical Measures NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd.
- This Multiple Sclerosis Discovery Could Be a Breakthroughon April 20, 2024 at 5:00 am
A new blood test reveals signs of the disease years before symptoms occur. It could change how MS is diagnosed, treated and studied.
via Bing News